Form 8-K - Current report:
SEC Accession No. 0001140361-24-042883
Filing Date
2024-10-04
Accepted
2024-10-04 16:07:04
Documents
15
Period of Report
2024-10-01
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20036718_8k.htm   iXBRL 8-K 30875
2 EXHIBIT 10.1 ef20036718_ex10-1.htm EX-10.1 29691
3 EXHIBIT 10.2 ef20036718_ex10-2.htm EX-10.2 24171
  Complete submission text file 0001140361-24-042883.txt   230997

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA siga-20241001.xsd EX-101.SCH 3970
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE siga-20241001_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE siga-20241001_pre.xml EX-101.PRE 16036
17 EXTRACTED XBRL INSTANCE DOCUMENT ef20036718_8k_htm.xml XML 4052
Mailing Address 31 EAST 62ND STREET NEW YORK NY 10065
Business Address 31 EAST 62ND STREET NEW YORK NY 10065 212-672-9100
SIGA TECHNOLOGIES INC (Filer) CIK: 0001010086 (see all company filings)

EIN.: 133864870 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38436 | Film No.: 241354979
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)